ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 372950 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 372950; 2) Community: the network communities that were significantly associated with the response to NSC 372950; 3) Molecule: the relationships between components within communities and NSC 372950; 4) MDR: the compounds that were significantly associated with the NSC 372950.

NSC Compound Enrichment Correlation
NSC 677598 Glutamamide, N-acetyl-1-O-(phenylmethyl)-.alpha.-normuramyl-prolyl- N(5)-[5-[(1-nitro-9-acridinyl)amino]pentyl]-, stereoisomer 0.0284045326811618 0.40413275
NSC 678355 L-LYS-L-p-NO2Phe-L-Ala-L-p-NO2PheNH2 0.0284045326811618 0.40024723
NSC 682764 Pyrido[3,2-d][1]benzazepin-6-one, 4-(4-chlorophenyl)-2-phenyl- 0.0284045326811618 -0.019991296
NSC 688326 Null 0.0284045326811618 0.052619536
NSC 690270 ANTINEOPLASTIC-690270 0.0284045326811618 0.2969005
NSC 696127 Null 0.0284045326811618 0.24773215
NSC 696558 N-(4-Amino-4-deoxy-N10-methypteroyl)-D,L-homocysteic acid 0.0284045326811618 0.58688491
NSC 698058 Null 0.0284045326811618 0.41360653
NSC 703092 Null 0.0284045326811618 0.35418345
NSC 704115 4H-Cyclopenta[c]thiophen-4-one, 6-amino-1-chloro-5,6-dihydro-, hydrochloride 0.0284045326811618 0.2617414
Total:169  Current:112    [First] [Prev] [Next] [Last]